These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 9950893

  • 1. Endothelin-1 is elevated in monocrotaline pulmonary hypertension.
    Frasch HF, Marshall C, Marshall BE.
    Am J Physiol; 1999 Feb; 276(2):L304-10. PubMed ID: 9950893
    [Abstract] [Full Text] [Related]

  • 2. Endothelin-1 mediates nitro-L-arginine vasoconstriction of hypertensive rat lungs.
    Muramatsu M, Rodman DM, Oka M, McMurtry IF.
    Am J Physiol; 1997 May; 272(5 Pt 1):L807-12. PubMed ID: 9176242
    [Abstract] [Full Text] [Related]

  • 3. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
    Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, Goto K.
    Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258
    [Abstract] [Full Text] [Related]

  • 4. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP, Dai ZK, Huang CH, Yeh JL, Wu BN, Wu JR, Chen IJ.
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [Abstract] [Full Text] [Related]

  • 5. Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade.
    Jasmin JF, Cernacek P, Dupuis J.
    Clin Sci (Lond); 2003 Dec; 105(6):647-53. PubMed ID: 12823096
    [Abstract] [Full Text] [Related]

  • 6. Hypoxia inhibits increased ETB receptor-mediated NO synthesis in hypertensive rat lungs.
    Sato K, Rodman DM, McMurtry IF.
    Am J Physiol; 1999 Apr; 276(4):L571-81. PubMed ID: 10198355
    [Abstract] [Full Text] [Related]

  • 7. Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats.
    Sasaki A, Doi S, Mizutani S, Azuma H.
    Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1480-7. PubMed ID: 17322279
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of separate and combined ETA and ETB blockade on ET-1-induced constriction in perfused rat lungs.
    Sato K, Oka M, Hasunuma K, Ohnishi M, Sato K, Kira S.
    Am J Physiol; 1995 Nov; 269(5 Pt 1):L668-72. PubMed ID: 7491987
    [Abstract] [Full Text] [Related]

  • 10. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
    Hill NS, Warburton RR, Pietras L, Klinger JR.
    J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
    [Abstract] [Full Text] [Related]

  • 11. Roles of endothelin ETA and ETB receptors in the pathogenesis of monocrotaline-induced pulmonary hypertension.
    Nishida M, Eshiro K, Okada Y, Takaoka M, Matsumura Y.
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):187-91. PubMed ID: 15243299
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y.
    Respiration; 2006 Aug; 73(1):105-12. PubMed ID: 16432296
    [Abstract] [Full Text] [Related]

  • 14. Differential roles of endothelin-1 ETA and ETB receptors and vasoactive intestinal polypeptide in regulation of the airways and the pulmonary vasculature in isolated rat lung.
    Janosi T, Peták F, Fontao F, Morel DR, Beghetti M, Habre W.
    Exp Physiol; 2008 Nov; 93(11):1210-9. PubMed ID: 18567602
    [Abstract] [Full Text] [Related]

  • 15. Endothelin-3 regulation of retinal hemodynamics in nondiabetic and diabetic rats.
    Mori F, King GL, Clermont AC, Bursell DK, Bursell SE.
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3955-62. PubMed ID: 11053299
    [Abstract] [Full Text] [Related]

  • 16. Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats.
    Mam V, Tanbe AF, Vitali SH, Arons E, Christou HA, Khalil RA.
    J Pharmacol Exp Ther; 2010 Feb; 332(2):455-62. PubMed ID: 19915069
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
    Prié S, Leung TK, Cernacek P, Ryan JW, Dupuis J.
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1312-8. PubMed ID: 9316840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.